Harnessing Advanced Machine Learning Techniques for Microscopic Vessel Segmentation in Pulmonary Fibrosis Using Novel Hierarchical Phase-Contrast Tomography Images
- PMID: 39965755
- PMCID: PMC12133326
- DOI: 10.1055/a-2540-8166
Harnessing Advanced Machine Learning Techniques for Microscopic Vessel Segmentation in Pulmonary Fibrosis Using Novel Hierarchical Phase-Contrast Tomography Images
Abstract
Background: Fibrotic lung disease is a progressive illness that causes scarring and ultimately respiratory failure, with irreversible damage by the time it is diagnosed on computed tomography imaging. Recent research postulates the role of the lung vasculature on the pathogenesis of the disease. With the recent development of high-resolution hierarchical phase-contrast tomography (HiP-CT), we have the potential to understand and detect changes in the lungs long before conventional imaging. However, to gain quantitative insight into vascular changes you first need to be able to segment the vessels before further downstream analysis can be conducted. Aside from this, HiP-CT generates large-volume, high-resolution data which is time-consuming and expensive to label.
Objectives: This project aims to qualitatively assess the latest machine learning methods for vessel segmentation in HiP-CT data to enable label propagation as the first step for imaging biomarker discovery, with the goal to identify early-stage interstitial lung disease amenable to treatment, before fibrosis begins.
Methods: Semisupervised learning (SSL) has become a growing method to tackle sparsely labeled datasets due to its leveraging of unlabeled data. In this study, we will compare two SSL methods; Seg PL, based on pseudo-labeling, and MisMatch, using consistency regularization against state-of-the-art supervised learning method, nnU-Net, on vessel segmentation in sparsely labeled lung HiP-CT data.
Results: On initial experimentation, both MisMatch and SegPL showed promising performance on qualitative review. In comparison with supervised learning, both MisMatch and SegPL showed better out-of-distribution performance within the same sample (different vessel morphology and texture vessels), though supervised learning provided more consistent segmentations for well-represented labels in the limited annotations.
Conclusion: Further quantitative research is required to better assess the generalizability of these findings, though they show promising first steps toward leveraging this novel data to tackle fibrotic lung disease.
The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution License, permitting unrestricted use, distribution, and reproduction so long as the original work is properly cited. (https://creativecommons.org/licenses/by/4.0/).
Conflict of interest statement
P.V. acknowledges funding from the UKRI Centre for Doctoral Training (CDT) in AI-enabled Healthcare Systems, supported by UKRI grant (EP/S021612/1). J.J. was also supported by the NIHR UCLH Biomedical Research Centre.
Figures













References
-
- NHS . Lung Health Checks. Accessed July 15, 2023 at:https://www.nhs.uk/conditions/lung-health-checks/
-
- National Institute for Health and Care Excellence (NICE) . Lung Cancer: Diagnosis and Management. NICE Guideline [NG122]. Updated March 8,2024. Accessed May 30, 2024 at:https://www.nice.org.uk/guidance/ng122/chapter/Recommendations-for-resea...
-
- Gov.UK . New lung cancer screening roll-out to detect cancer sooner.2023. Accessed July 17, 2023 at:https://www.gov.uk/government/news/new-lung-cancer-screening-roll-out-to...
-
- Hewitt R J, Bartlett E C, Ganatra R et al.Lung cancer screening provides an opportunity for early diagnosis and treatment of interstitial lung disease. Thorax. 2022;77(11):1149–1151. - PubMed
-
- Mayo Clinic . Pulmonary Fibrosis: Symptoms and Causes. Updated2018. Accessed June 13, 2023 at:https://www.mayoclinic.org/diseases-conditions/pulmonary-fibrosis/sympto...